BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20412041)

  • 1. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
    Choudhary AN; Kumar A; Juyal V
    Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
    Pontiki E; Hadjipavlou-Litina D
    Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
    Eleni P; Dimitra HL
    Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study on 5-lipoxygenase inhibitors using distance-based topological indices.
    Agrawal VK; Bano S; Khadikar PV
    Bioorg Med Chem; 2003 Dec; 11(24):5519-27. PubMed ID: 14642596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
    Tan CM; Chen GS; Chen CS; Chang PT; Chern JW
    Bioorg Med Chem; 2011 Nov; 19(21):6316-28. PubMed ID: 21958737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
    Sinha S; Doble M; Manju SL
    Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational Use of Heterogeneous Data in Quantitative Structure-Activity Relationship (QSAR) Modeling of Cyclooxygenase/Lipoxygenase Inhibitors.
    Lagunin AA; Geronikaki A; Eleftheriou P; Pogodin PV; Zakharov AV
    J Chem Inf Model; 2019 Feb; 59(2):713-730. PubMed ID: 30688458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
    Leonard JT; Roy K
    Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analogues.
    Kim KH; Martin YC; Brooks DW; Dyer RD; Carter GW
    J Pharm Sci; 1994 Mar; 83(3):433-8. PubMed ID: 8207697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study on 5-lipoxygenase inhibitors based on support vector machine.
    Niu B; Su Q; Yuan X; Lu W; Ding J
    Med Chem; 2012 Nov; 8(6):1108-16. PubMed ID: 22779798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
    Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P
    Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic.
    Camargo AB; Marchevsky E; Luco JM
    J Agric Food Chem; 2007 Apr; 55(8):3096-103. PubMed ID: 17367159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors.
    Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK
    Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a novel thiophene inhibitor of 15-lipoxygenase-1 with both anti-inflammatory and neuroprotective properties.
    Eleftheriadis N; Poelman H; Leus NGJ; Honrath B; Neochoritis CG; Dolga A; Dömling A; Dekker FJ
    Eur J Med Chem; 2016 Oct; 122():786-801. PubMed ID: 27477687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties.
    Pontiki E; Hadjipavlou-Litina D; Patsilinakos A; Tran TM; Marson CM
    Future Med Chem; 2015; 7(14):1937-51. PubMed ID: 26423719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of more potent squalene synthase inhibitors with multiple activities.
    Kourounakis AP; Matralis AN; Nikitakis A
    Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase.
    Hofmann B; Franke L; Proschak E; Tanrikulu Y; Schneider P; Steinhilber D; Schneider G
    ChemMedChem; 2008 Oct; 3(10):1535-8. PubMed ID: 18688907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.